SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 35 of 51
Word Count: 1486
Character Count: 9387

Document Content:

offering, except for the quotation of our common stock on the OTCQB, there has not been an active market for our common stock and there has been no public market for our warrants. The public offering price for our Units will be determined through negotiations between us and the underwriters. Among the factors to be considered in these negotiations will be prevailing market conditions, our financial information, market valuations of other companies that we and the underwriters believe to be comparable to us, estimates of our business potential, the present state of our development and other factors deemed relevant. We offer no assurances that the public offering price of our Units will correspond to the price at which our common stock will trade in the public market subsequent to this offering or that an active trading market for our common stock will develop and continue after this offering. Representative’s Warrants

We have agreed to issue to the Representative (or its permitted assignees)
warrants to purchase up to a total of [ ] shares of common stock (8% of the shares of common stock included in the Units, excluding the
over-allotment, if any). The warrants will be exercisable at any time, and from time to time, in whole or in part, commencing six months
from the effective date of the registration statement of which this prospectus is a part and will expire five years from such effective
date, which period is in compliance with FINRA Rule 5110(f)(2)(G)(i). The warrants are exercisable at a per share price equal to $[ ]
per share, or [_]% of the public offering price per Unit in the offering (based on the public offering price of $[ ] per Unit). The warrants
have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA. The Representative
(or permitted assignees under Rule 5110(g)(1)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities
underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in
the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the
registration statement of which this prospectus is a part. In addition, the warrants provide for certain piggyback registration rights
upon request, in certain cases. The piggyback registration rights provided will not be greater than 5 years from the effective date of
the registration statement of which this prospectus is a part in compliance with FINRA Rule 5110(f)(2)(G)(v). We will bear all fees and
expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and
payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation.
However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below
the warrant exercise price. In addition, the holders thereof shall have the right to exercise the warrants via a cashless exercise feature,
and on the expiration date of such warrants, they shall be automatically exercised via cashless exercise pursuant to the terms of such
warrants.

Right of First Refusal and Certain Post-Offering Investments

Subject to the closing of this offering and certain conditions set
forth in the underwriting agreement, for a period of eighteen (18) months after the closing of the offering, the Representative shall
have a right of first refusal to act as lead managing underwriter and book-runner and/or placement agent for any and all future public
or private equity, equity-linked or debt (excluding commercial bank debt) offerings undertaken during such period by us, or any of our
successors or subsidiaries, on terms customary to the Representative. The Representative in conjunction with us, shall have the sole right
to determine whether or not any other broker-dealer shall have the right to participate in any such offering and the economic terms of
any such participation. In addition, we have also agreed that in the event any investor previously directly introduced to us by the underwriters
subsequently provides capital to us in any transaction, other than via any exercise of warrants issued in this offering, for a period
of eighteen (18) months following the closing of the offering, we will pay the underwriters a cash fee of 8.0% of the gross proceeds on
any such investments.

Subsequent Equity Sales; Capital Changes

Pursuant to the underwriting
agreement, subject to certain exceptions, from the date of such agreement until 120 days after the closing date of the offering, neither
the Company nor any of its subsidiaries shall issue, or solicit, negotiate with, or enter into any agreement with any source of financing
(whether equity, debt or otherwise) other than the Representative, in connection with an offering or proposed offering of the Company’s
debt or equity securities or any other financing by the Company, and the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its subsidiaries of common stock or common stock equivalents (or a combination
of units thereof) involving a Variable Rate Transaction (as defined in such underwriting agreement). In addition, until 120 days after
the closing of this offering and except for the Reverse Stock Split, the Company shall not undertake a reverse or forward stock split
or reclassification of its common stock without the prior written consent of the Representative.

Trading; NASDAQ Capital Market Listing

Our common stock is presently
quoted on the OTCQB under the symbol “DUKR.” We intend to apply to list our common stock and warrants on Nasdaq under the
symbols “DUKR” and “DUKRW”, respectively. No assurance can be given that our listing application will be approved
by Nasdaq.

Price Stabilization, Short Positions and Penalty Bids

In connection with this offering
the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering transactions and penalty bids
in accordance with Regulation M under the Exchange Act:

●	Stabilizing transactions permit bids to purchase securities so long as the stabilizing bids do not exceed a specified maximum.

●	Over-allotment involves sales by the underwriters of securities in excess of the number of securities the underwriters are obligated to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position, the number of securities over-allotted by the underwriters is not greater than the number of securities that they may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number of securities in the over-allotment option. The underwriters may close out any covered short position by either exercising their over-allotment option and/or purchasing securities in the open market.

●	Syndicate covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of securities to close out the short position, the underwriters will consider, among other things, the price of securities available for purchase in the open market as compared to the price at which they may purchase securities through the over-allotment option. A naked short position occurs if the underwriters sell more securities than could be covered by the over-allotment option. This position can only be closed out by buying securities in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the securities in the open market after pricing that could adversely affect investors who purchase in this offering.

●	Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when securities originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.

These stabilizing transactions,
syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our securities or preventing
or retarding a decline in the market price of the securities. As a result, the price of our shares of common stock may be higher than
the price that might otherwise exist in the open market. These transactions may be discontinued at any time.

Neither we nor the underwriters
make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on
the price of our shares of common stock. In addition, neither we nor the underwriters make any representation that the underwriters will
engage in these transactions or that any transaction, if commenced, will not be discontinued without notice.

Electronic Offer, Sale and Distribution of Units